Popular diabetes and weight loss drugs may do more than curb appetites — they may also help reduce the risk of dementia, according to new research. Two studies that noted this unexpected effect ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related cancers, especially colorectal cancer, according to data released on ...